KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Gains from Sales and Divestitures (2020 - 2021)

Progyny (PGNY) has disclosed Gains from Sales and Divestitures for 2 consecutive years, with $201916.0 as the latest value for Q4 2021.

  • On a quarterly basis, Gains from Sales and Divestitures rose 319.82% to $201916.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $201916.0, a 319.82% increase, with the full-year FY2021 number at $201916.0, up 319.82% from a year prior.
  • Gains from Sales and Divestitures was $201916.0 for Q4 2021 at Progyny, up from $48096.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $201916.0 in Q4 2021 to a low of $48096.0 in Q4 2020.